Kenny Luong
Foot & Ankle Surgery · West Nyack, NYNPI 1962066076
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $41,426 of the $57,787 with a category attached, or 71.7%. Lifenet Health accounts for 80.1% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $39,268, 5.9 times the $6,663 reported in 2022. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $352.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lifenet Health$46K
- Seapearl East, Inc$4K
- Stryker$3K
- Paragon 28, Inc.$2K
- Smith+Nephew$363
- Treace Medical Concepts, Inc.$253
- plus $2K from 26 others
What the payments were for
- Consulting fees$41,42672%
- Travel & lodging$6,52411%
- Food & beverage$6,23711%
- Education$3,6006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lifenet Health | 49 | $46,310 |
| Seapearl East, Inc | 12 | $4,004 |
| Stryker | 24 | $3,079 |
| Paragon 28, Inc. | 13 | $1,962 |
| Smith+Nephew | 12 | $363 |
| Treace Medical Concepts, Inc. | 5 | $253 |
| Extremity Medical | 1 | $195 |
| Organogenesis Inc. | 3 | $175 |
| Next Science LLC | 3 | $170 |
| Paratek Pharmaceuticals, Inc. | 8 | $161 |
| Amgen(2 entities) | 4 | $126 |
| Kerecis Limited | 1 | $116 |
| Fusion Orthopedics USA, LLC | 1 | $102 |
| Johnson & Johnson(2 entities) | 3 | $100 |
| Bone Support Inc. | 2 | $78 |
| Curonix LLC | 3 | $69 |
| Integra Lifesciences Corporation | 2 | $69 |
| Highridge Medical LLC | 1 | $46 |
| Zimmer Biomet | 1 | $45 |
| Nevro Corp. | 2 | $43 |
| Dynasplint Systems Inc. | 1 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $40 |
| Tactile Systems Technology Inc | 1 | $38 |
| Averitas Pharma Inc. | 2 | $35 |
| Urgo Medical North America, LLC | 1 | $26 |
| Medtronic | 1 | $24 |
| IBSA Pharma Inc. | 1 | $24 |
| Bioventus LLC | 1 | $23 |
| Convatec Inc. | 1 | $22 |
| Solventum Corporation | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraGenesis Wound Matrix$45,477
- PROstep$1,572
- Product Portfolio$538
- MONKEY RINGS$534
- Portfolio$502
- Kerecis SurgiClose$463
- AUGMENT INJECTABLE$451
- IO FiX$195
- VALOR$175
- SurgX$146
- Xperience$146
- BlastX$146
- CITREFIX$144
- HOFFMANN$144
- PROSTEP MICA$144
- APEX 3D$138
- Precision MIS Bunion$134
- GRAFIX PL$132
- Affinity$125
- Kerecis GraftGuide$116
How this compares
$57,787 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 17 | $9,464 |
| Gentamicin Sulfate | 13 | $341 |
| Ammonium Lactate | 11 | $299 |
| Doxycycline Hyclate | 30 | $227 |
| Ciprofloxacin Hcl | 28 | $170 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $160 |
| Mupirocin | 16 | $118 |
| Meloxicam | 46 | $106 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $363 | $9,46417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in West Nyack
- Todd StewartWest Nyack$21K
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.